Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Renaissance BioScience Secures An Australian Patent for Novel RNA Production and Delivery Technology





Proprietary yeast-based technology platform for producing and delivering RNA with applications in multiple large-scale global industries

VANCOUVER, BC, September 04, 2025 /24-7PressRelease/ -- Renaissance BioScience Corp. is pleased to announce that it has been granted another patent for its innovative yeast-based platform technology for the low-cost production and effective delivery of RNA. The new patent, awarded by the Australian patent office, is the second patent awarded for this RNA technology IP, with more jurisdictions pending. The first patent was awarded by China. This Australian patent joins the company's extensive IP portfolio of issued and pending patents for multiple end-use markets.

Renaissance's most commercially advanced application of its yeast-based RNA production and delivery system is a suite of RNAi-based biopesticide products designed for a precise, targeted approach to pest control. These RNAi-based biopesticides have an improved environmental safety profile compared to broad spectrum chemical pesticides but with similar cost structures when produced at scale. Importantly, this technology works seamlessly with existing farming practices and equipment.

As Australia is one of the world's most innovative and largest agricultural economies, the timing of this patent issuance corresponds well with Renaissance's current commercial agriculture application of this powerful technology.

In addition to use as a safe, effective and inexpensive insecticide for agriculture and other insect biocontrol uses, this RNA technology platform holds excellent potential in additional multi-billion-dollar market applications, particularly for animal health and human medicines.

Yeast-based platform technology addresses key challenges of RNA for broad industry uses

RNA is a powerful tool but has been restricted from use in many industrial applications due to a high cost of production and extreme fragility of the RNA molecules. The Renaissance RNA technology platform solves these problems and allows for significantly expanded use of RNA across multiple industries.

About Renaissance BioScience Corp.
Based in Vancouver, Canada, Renaissance is a global leading yeast bioengineering company developing innovative, market-ready, functional microorganisms that provide cost-effective solutions to address a broad range of environmental, health and industrial challenges in agriculture, animal and human health, food and beverage, and energy. More information: www.renaissancebioscience.com.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.